Jay R. Campbell
Direttore/Membro del Consiglio presso Update Pharma, Inc.
Posizioni attive di Jay R. Campbell
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Update Pharma, Inc.
 Update Pharma, Inc. Medical DistributorsDistribution Services Part of MDM Permian, Inc., Update Pharma, Inc. develops and provides anti-cancer drugs and other pharmaceutical products. The American company was founded by William James Garner. Update Pharma was acquired by BestnPet, Inc. on September 09, 2013. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Jay R. Campbell
Precedenti posizioni note di Jay R. Campbell
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Kolltan Pharmaceuticals, Inc.
 Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Corporate Officer/Principal | - | - |
| IMMUTEP LIMITED | Contatto Relazioni con gli Investitori | 01/02/2017 | - |
Formazione di Jay R. Campbell
| Bucknell University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Australia | 2 |
Posizioni
| Investor Relations Contact | 1 |
| Undergraduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
| Distribution Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| IMMUTEP LIMITED | Health Technology |
| Aziende private | 2 |
|---|---|
Kolltan Pharmaceuticals, Inc.
Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Health Technology |
Update Pharma, Inc.
Update Pharma, Inc. Medical DistributorsDistribution Services Part of MDM Permian, Inc., Update Pharma, Inc. develops and provides anti-cancer drugs and other pharmaceutical products. The American company was founded by William James Garner. Update Pharma was acquired by BestnPet, Inc. on September 09, 2013. | Distribution Services |
- Borsa valori
- Insiders
- Jay R. Campbell
- Esperienza
